These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 27338851)
1. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma. Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851 [TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma. Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086 [TBL] [Abstract][Full Text] [Related]
3. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma. Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475 [TBL] [Abstract][Full Text] [Related]
4. Methylation-mediated downregulation of long noncoding RNA LOC100130476 in gastric cardia adenocarcinoma. Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Wang G Clin Exp Metastasis; 2016 Jun; 33(5):497-508. PubMed ID: 27189370 [TBL] [Abstract][Full Text] [Related]
5. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858 [TBL] [Abstract][Full Text] [Related]
6. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer. Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329 [TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma. Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma. Liu Z; Yang T; Xu Z; Cao X Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379 [TBL] [Abstract][Full Text] [Related]
9. Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LET. Chen Z; Lin J; Wu S; Xu C; Chen F; Huang Z Exp Cell Res; 2018 Jan; 362(1):90-101. PubMed ID: 29126868 [TBL] [Abstract][Full Text] [Related]
10. Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells. Li W; Zheng J; Deng J; You Y; Wu H; Li N; Lu J; Zhou Y Gastroenterology; 2014 Jun; 146(7):1714-26.e5. PubMed ID: 24631494 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496 [TBL] [Abstract][Full Text] [Related]
12. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients. Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140 [TBL] [Abstract][Full Text] [Related]
13. Methylation Mediated Downregulation of TOB1-AS1 and TOB1 Correlates with Malignant Progression and Poor Prognosis of Esophageal Squamous Cell Carcinoma. Dong Z; Zhang G; Lu J; Guo Y; Liang J; Shen S; Guo W Dig Dis Sci; 2023 Apr; 68(4):1316-1331. PubMed ID: 36002674 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA, tissue differentiation-inducing nonprotein coding RNA is upregulated and promotes development of esophageal squamous cell carcinoma. Xu Y; Qiu M; Chen Y; Wang J; Xia W; Mao Q; Yang L; Li M; Jiang F; Xu L; Yin R Dis Esophagus; 2016 Nov; 29(8):950-958. PubMed ID: 26833746 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA CCAT2 correlates with smoking in esophageal squamous cell carcinoma. Wang J; Qiu M; Xu Y; Li M; Dong G; Mao Q; Yin R; Xu L Tumour Biol; 2015 Jul; 36(7):5523-8. PubMed ID: 25677908 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Chen FJ; Sun M; Li SQ; Wu QQ; Ji L; Liu ZL; Zhou GZ; Cao G; Jin L; Xie HW; Wang CM; Lv J; De W; Wu M; Cao XF Mol Carcinog; 2013 Nov; 52(11):908-15. PubMed ID: 24151120 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer. Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis. Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022 [TBL] [Abstract][Full Text] [Related]
19. A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma. Pan F; Yao J; Chen Y; Zhou C; Geng P; Mao H; Fang X Int J Clin Exp Pathol; 2014; 7(6):2838-49. PubMed ID: 25031703 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma. Ren ZP; Chu XY; Xue ZQ; Zhang LB; Wen JX; Deng JQ; Hou XB Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3866-3870. PubMed ID: 28975978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]